Skip to main content
Industry Update
Access in all areas? A roundup of developments in market access and health technology assessment: part 6
- Annie Jullien Pannelay,
- Ramiro E Gilardino, and
- Sreeram V Ramagopalan
e240239
Published Online:10 January 2025
Plain Language Summary of Publication
Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas that can't be removed by surgery, and impact on how the condition affects caregivers: a plain language summary
- Yulia Dinikina,
- Marina Dorofeeva, and
- Fatima Nakhusheva
e240184
Published Online:21 January 2025
Short Report
Clinical characteristics and treatment outcomes in multiple sclerosis patients treated with anti-CD20s who switched to fumarates: a retrospective analysis of a US healthcare claims database
- Aliza B Ben-Zacharia,
- Jenny J Feng,
- Brandon P Moss,
- Nicholas Belviso,
- Yu Zhang,
- Filipe Branco,
- Jason P Mendoza,
- James B Lewin, and
- Sarah M England
e240071
Published Online:12 February 2025
Research Article
The economic impact of stent retriever selection for acute ischemic stroke: a cost analysis of MASTRO I from the healthcare system perspective of the United States, Canada and eight European countries
- Tommy Andersson,
- Hannes Nordmeyer,
- Waleed Brinjikji,
- Emilie Kottenmeier,
- Mina Kabiri,
- Shanti Scheffler,
- Patrick A Brouwer,
- Mahmood Mirza, and
- Osama O Zaidat
e240216
Published Online:17 February 2025
Budget impact analyses of hemoglobin A1c and lipid panel point-of-care testing with Afinion™ 2 in Canada and Italy
- David Garcia,
- Antonio Ruffolo,
- Alicyia Walczyk Mooradally,
- Anna Zhou,
- Emmanuel Lazaridis, and
- Barbara Laurelli
e240208
Published Online:29 January 2025
Economic impact of reduced postoperative visits after inflatable penile prosthesis implantation
- Bradley Gill,
- Young Eun Shin,
- Kathryn Durand,
- Andrew Sun,
- Paurush Babbar, and
- Sirikan Rojanasarot
e240204
Published Online:15 January 2025
- This article corrects the following:
Corrigendum
- Volume 14Issue 7Journal of Comparative Effectiveness Research
- 6 May 2025
The impact of a patient advisory board on a clinical comparative effectiveness trial: a comparison of patient and researcher perspectives
- Laura M Kernan,
- Monica Baczko Pearl,
- Adina Harri,
- Carol A Lambourne,
- Robert Schlegel,
- C. McCollister Evarts,
- Mary Beth Crummer,
- Conrad Persels,
- Nancy Mullen, and
- Vincent D Pellegrini
e240050
Published Online:30 January 2025
Meta-Analysis
Efficacy of treatment options for complicated urinary tract infections including acute pyelonephritis: a systematic literature review and network meta-analysis
- Florian Wagenlehner,
- Verónica Rico Caballero,
- Vikalp Maheshwari,
- Ayantika Biswas,
- Priyanka Saini,
- Juan Quevedo,
- Juergen Polifka,
- Leonardo Ruiz, and
- Sandrine Cure
e240214
Published Online:16 January 2025
Correction
Corrigendum
e240241
Published Online:7 January 2025
- Correction(s) for this article
Real-world direct healthcare costs of treating recurrent high-grade serous ovarian cancer with cytotoxic chemotherapy
- Volume 9Issue 8Journal of Comparative Effectiveness Research
- 30 March 2020